Kerstin Borgmann
Impact in
- Cancer Research top 2%
- Carcinogens and Genotoxicity Assessment
- Oncology top 2%
- PARP inhibition in cancer therapy
- Cancer Cells and Metastasis
- Cancer-related Molecular Pathways
Papers in
- Oncology 42
- PARP inhibition in cancer therapy 24
- Cancer-related Molecular Pathways 8
-
- Carcinogens and Genotoxicity Assessment 14
- Co-authors
- Ekkehard DikomeyCordula PetersenWael MansourFelix MeyerAnna DubrovskaAlexander SchulzJochen Dahm‐DaphiMechthild Krause
- Journals
- Radiotherapy and Oncology (13 papers)Cancers (7 papers)Oncotarget (6 papers)Strahlentherapie und Onkologie (5 papers)International Journal of Radiation Oncology*Biology*Physics (4 papers)
- Partner nations
- GermanyUnited StatesEgypt
In The Last Decade
Kerstin Borgmann
84 papers receiving 2.7k citations
Peers
Comparison fields: 5 of 103
- Cancer Research 712
- Oncology 1.2k
- Molecular Biology 1.8k
- Radiology, Nuclear Medicine and Imaging 504
- Otorhinolaryngology 76
Countries citing papers authored by Kerstin Borgmann
This map shows the geographic impact of Kerstin Borgmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kerstin Borgmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kerstin Borgmann more than expected).
Fields of papers citing papers by Kerstin Borgmann
This network shows the impact of papers produced by Kerstin Borgmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kerstin Borgmann. The network helps show where Kerstin Borgmann may publish in the future.
Co-authors
The 25 scholars most cited alongside Kerstin Borgmann, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 7 | |
| 2 | 2023 | 1 | |
| 3 | 2022 | 9 | |
| 4 | 2022 | 4 | |
| 5 | 2021 | 9 | |
| 6 | 2021 | 31 | |
| 7 | 2020 | 13 | |
| 8 | 2019 | 49 | |
| 9 | 2017 | 11 | |
| 10 | 2016 | 41 | |
| 11 | 2016 | 15 | |
| 12 | 2014 | 14 | |
| 13 | 2013 | 35 | |
| 14 | 2013 | 50 | |
| 15 | 2011 | 14 | |
| 16 | 2010 | 154 | |
| 17 | 2009 | 12 | |
| 18 | 2008 | 77 | |
| 19 | 2007 | 5 | |
| 20 | 2003 | 62 |
About Kerstin Borgmann
Kerstin Borgmann is a scholar working on Oncology, Cancer Research, Molecular Biology, Radiology, Nuclear Medicine and Imaging and Pulmonary and Respiratory Medicine, having authored 85 papers that have together received 2.7k indexed citations. Recurring topics across this work include DNA Repair Mechanisms (45 papers), PARP inhibition in cancer therapy (24 papers), Carcinogens and Genotoxicity Assessment (14 papers), Effects of Radiation Exposure (11 papers), CRISPR and Genetic Engineering (10 papers), Cancer-related Molecular Pathways (8 papers), Cancer therapeutics and mechanisms (7 papers) and Genomics and Chromatin Dynamics (7 papers). The work is most often cited by research in Cancer Research (712 citations), Oncology (1.2k citations), Molecular Biology (1.8k citations), Radiology, Nuclear Medicine and Imaging (504 citations) and Otorhinolaryngology (76 citations). Kerstin Borgmann has collaborated with scholars based in Germany, United States and Egypt. Frequent co-authors include Ekkehard Dikomey, Cordula Petersen, Wael Mansour, Felix Meyer, Anna Dubrovska, Alexander Schulz, Jochen Dahm‐Daphi, Mechthild Krause, Ulrike Hoeller and Ann Christin Parplys. Their work appears in journals such as Radiotherapy and Oncology, Cancers, Oncotarget, Strahlentherapie und Onkologie and International Journal of Radiation Oncology*Biology*Physics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.